Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia

Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia

Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are hematologic malignancies arising from the bone marrow. Despite recent advances in treating these diseases, patients with higher-risk MDS and AML continue to have a poor prognosis with limited survival. It has long been recognized t...

Full description

Bibliographic Details
Main Authors: Sargam Kapoor, Grace Champion, Aparna Basu, Anu Mariampillai, Matthew J. Olnes
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Cancers
Subjects:
acute myeloid leukemia
myelodysplastic syndromes
immune therapy
monoclonal antibody
antibody drug conjugate
CAR T-cells
Online Access:https://www.mdpi.com/2072-6694/13/19/5026

Internet

https://www.mdpi.com/2072-6694/13/19/5026

Similar Items